KR100769578B1 - Cosmetic Composition against Aging of the Skin - Google Patents

Cosmetic Composition against Aging of the Skin Download PDF

Info

Publication number
KR100769578B1
KR100769578B1 KR1020030072540A KR20030072540A KR100769578B1 KR 100769578 B1 KR100769578 B1 KR 100769578B1 KR 1020030072540 A KR1020030072540 A KR 1020030072540A KR 20030072540 A KR20030072540 A KR 20030072540A KR 100769578 B1 KR100769578 B1 KR 100769578B1
Authority
KR
South Korea
Prior art keywords
skin
cosmetic composition
hydroxybuffapten
skin wrinkles
improving skin
Prior art date
Application number
KR1020030072540A
Other languages
Korean (ko)
Other versions
KR20050037105A (en
Inventor
진무현
이상화
박양미
강상진
Original Assignee
주식회사 엘지생활건강
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 엘지생활건강 filed Critical 주식회사 엘지생활건강
Priority to KR1020030072540A priority Critical patent/KR100769578B1/en
Priority to JP2006535260A priority patent/JP4129475B2/en
Priority to US10/575,974 priority patent/US20070065377A1/en
Priority to PCT/KR2004/002418 priority patent/WO2005037270A1/en
Priority to CNB2004800336572A priority patent/CN100542527C/en
Publication of KR20050037105A publication Critical patent/KR20050037105A/en
Application granted granted Critical
Publication of KR100769578B1 publication Critical patent/KR100769578B1/en
Priority to US12/405,964 priority patent/US20090233997A1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02Preparations containing skin colorants, e.g. pigments
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Cosmetics (AREA)

Abstract

본 발명은 피부 주름 개선용 화장료 조성물에 관한 것으로서, 더욱 상세하게는 8-히드록시버갑텐(8-hydroxybergapten : 5-benzofuranacrylic acid,6,7-dihydroxy-4-methoxy-,δ-lactone)을 유효성분으로 포함하는 피부 주름 개선용 화장료 조성물에 관한 것이다. The present invention relates to a cosmetic composition for improving skin wrinkles, and more particularly, 8-hydroxybergapten (8-hydroxybergapten: 5-benzofuranacrylic acid, 6,7-dihydroxy-4-methoxy-, δ-lactone) effective It relates to a cosmetic composition for improving skin wrinkles comprising as a component.

본 발명의 피부 주름 개선용 화장료 조성물은 피부의 섬유아세포의 콜라겐 합성을 촉진함으로써, 피부의 탄력을 향상시키고 주름을 개선하는 효과가 매우 우수하다. The cosmetic composition for improving skin wrinkles of the present invention promotes collagen synthesis of fibroblasts of the skin, and thus has an excellent effect of improving skin elasticity and improving wrinkles.

8-히드록시버갑텐, 콜라겐, 피부 주름 개선, 화장료 8-hydroxybuffapten, collagen, skin wrinkle improvement, cosmetic

Description

피부 주름 개선용 화장료 조성물{Cosmetic Composition against Aging of the Skin} Cosmetic composition for improving skin wrinkles {Cosmetic Composition against Aging of the Skin}

도 1은 8-히드록시버갑텐의 1H-NMR 스펙트럼을 나타낸다. 1 shows the 1 H-NMR spectrum of 8-hydroxybuffaptene.

도 2는 8-히드록시버갑텐의 13C-NMR 스펙트럼을 나타낸다. 2 shows the 13 C-NMR spectrum of 8-hydroxybuffapten.

도 3은 8-히드록시버갑텐의 Mass 스펙트럼을 나타낸다. 3 shows the mass spectrum of 8-hydroxybuffapten.

[산업상 이용분야] [Industrial use]

본 발명은 피부 주름 개선용 화장료 조성물에 관한 것으로서, 더욱 상세하게는 피부의 섬유아세포의 콜라겐합성을 촉진하여 피부의 탄력을 향상시키고, 피부 주름을 개선하는 효과가 우수한 피부 주름 개선용 화장료 조성물에 관한 것이다. The present invention relates to a cosmetic composition for improving skin wrinkles, and more particularly, to a skin composition for improving skin wrinkles by promoting collagen synthesis of fibroblasts of the skin to improve skin elasticity and improving skin wrinkles. will be.

[종래기술] [Private Technology]

세포 외 기질(matrix)의 주요 구성 성분인 콜라겐은 피부의 섬유아세포에서 생성되는 주요 기질 단백질로서 세포 외 간질에 존재한다. 또한, 생체 단백질 총 중량의 약 30%를 차지하는 중요한 단백질로서 견고한 3중 나선구조를 가지고 있다. 콜라겐은 피부, 건(tendon), 뼈 및 치아의 유기 물질의 대부분을 형성하는데, 특히 뼈와 피부(진피)에 그 포함량이 높다. 대부분의 다른 체 구조물에서는 섬유상 봉입체로서 존재한다. Collagen, a major component of the extracellular matrix, is present in the extracellular epilepsy as a major matrix protein produced by skin fibroblasts. It is also an important protein, accounting for about 30% of the total weight of biological proteins, and has a solid triple helix structure. Collagen forms most of the organic material of the skin, tendons, bones and teeth, especially in bones and skin (dermis). Most other sieve structures exist as fibrous inclusions.

콜라겐은 비교적 약한 면역원인데, 콜라겐의 나선 구조에 의한 잠재성 항원 결정인자의 차폐가 그 일부 원인이고, 이 나선 구조는 또한 콜라겐이 단백질 분해에 대한 내성을 갖도록 한다. 콜라겐의 주된 기능으로는 피부의 기계적 견고성, 결합조직의 저항력과 조직의 결합력, 세포 접착의 지탱, 세포 분할과 분화(유기체의 성장 혹은 상처 치유시)의 유도 등이 알려져 있다(Van der Rest 등, 1990). 이러한 콜라겐은 연령 및 자외선 조사에 의한 광노화에 의해 감소하며, 이는 피부의 주름 형성과 밀접한 연관이 있다고 알려져 있다(Arthur K. Balin et al., Aging and the skin, 1989). 또한 근래에 들어 피부 노화에 대한 광범위한 연구가 발전되면서 피부에서의 콜라겐의 중요한 기능이 밝혀지고 있다 Collagen is a relatively weak immunogen, partly due to the shielding of latent antigenic determinants by the helix structure of collagen, which also makes collagen resistant to proteolysis. The main functions of collagen are known as mechanical firmness of skin, resistance of connective tissue and binding of tissue, support of cell adhesion, induction of cell division and differentiation (in organic growth or wound healing) (Van der Rest et al. 1990). This collagen is reduced by age and photoaging by UV irradiation, which is known to be closely associated with wrinkle formation of the skin (Arthur K. Balin et al., Aging and the skin, 1989). In recent years, extensive research on skin aging has revealed an important function of collagen in skin.

종래에는 콜라겐의 피부 보습 효과를 이용하기 위하여 화장품 등에 콜라겐을 배합한 제품들이 출시되어 있으나, 이들 화장품 등은 콜라겐을 피부 표면에 도포하는 것으로서 고분자 물질인 콜라겐의 경피 흡수가 어려워 보습작용을 기대할 수 없으므로 본질적인 피부 기능 개선이라고 말할 수 없었다. Conventionally, products using collagen have been released in order to take advantage of collagen's skin moisturizing effect.However, these cosmetics apply collagen to the surface of the skin. It could not be said to be an essential skin function improvement.

이러한 문제를 해결하기 위하여 콜라겐 합성 촉진 물질에 대한 관심이 높아졌으며, 종래에 알려진 콜라겐 합성 촉진 물질로는 비타민 C, 레티노익산(retinoic acid), 발암증식인자(TGF : transforming growth factor)(Cardinale G. et al, Adv. Enzymol., 41, p. 425, 1974), 동물 태반 유래의 단백질(JP8-231370), 베툴린 산(betulinic acid)(JP8-208424), 클로렐라 추출물(JP9-40523, JP10-36283, 섬유아세포 증식 촉진작용) 등이 있다. In order to solve this problem, interest in collagen synthesis promoting material has been increased, and conventionally known collagen synthesis promoting materials include vitamin C, retinoic acid, and transforming growth factor (TGF) (Cardinale G. et al, Adv. Enzymol., 41, p. 425, 1974), protein from animal placenta (JP8-231370), betulinic acid (JP8-208424), chlorella extract (JP9-40523, JP10- 36283, promoting fibroblast proliferation).

그러나, 이들 물질은 피부적용시 자극과 발적 등의 안전성의 문제로 사용량의 제한이 있거나 효과가 미미하여 실질적으로 피부 기능 개선 효과를 기대할 수 없다. 따라서, 기존의 피부 주름 개선 화장료 조성물보다 생체에 안전하고 효과가 높은 새로운 피부 주름 개선용 화장료 조성물의 개발이 절실히 요망되고 있다. However, these substances have limited use or insignificant effects due to safety problems such as irritation and redness during skin application, and thus, a substantial improvement in skin function cannot be expected. Therefore, there is an urgent need for the development of a new skin wrinkle improvement cosmetic composition that is safer and more effective in vivo than the existing skin wrinkle improvement cosmetic composition.

본 발명은 상기와 같은 종래의 문제점을 해결하기 위한 것으로서, 본 발명의 목적은 콜라겐의 합성을 촉진하여 피부의 탄력을 향상시키고, 피부 주름을 개선하는 효과가 우수한 피부 주름 개선용 화장료 조성물을 제공하는 것이다. The present invention is to solve the conventional problems as described above, an object of the present invention to promote the synthesis of collagen to improve the elasticity of the skin, to provide a cosmetic composition for improving skin wrinkles excellent skin wrinkles will be.

상기 목적을 달성하기 위하여, 본 발명은 8-히드록시버갑텐(8-hydroxybergapten : 5-benzofuranacrylic acid,6,7-dihydroxy-4-methoxy-,δ-lactone)(이하 '8-히드록시버갑텐'이라 한다.)을 유효성분으로 포함하는 콜라겐 합성 촉진제 조성물을 제공한다.In order to achieve the above object, the present invention is 8-hydroxybergapten (8-hydroxybergapten: 5-benzofuranacrylic acid, 6,7-dihydroxy-4-methoxy-, δ-lactone) (hereinafter '8-hydroxy bergapten It provides a collagen synthesis promoter composition comprising a) as an active ingredient.

본 발명은 또한, 8-히드록시버갑텐을 유효성분으로 포함하는 피부 주름 개선용 화장료 조성물을 제공한다.The present invention also provides a cosmetic composition for improving skin wrinkles comprising 8-hydroxybuffapten as an active ingredient.

이하, 본 발명을 상세하게 설명한다. EMBODIMENT OF THE INVENTION Hereinafter, this invention is demonstrated in detail.

본 발명자들은 피부 주름 개선용 화장료 조성물의 유효성분으로서 우수한 콜라겐 합성 촉진 효과를 갖는 물질을 개발하던 중, 상기 8-히드록시버갑텐이 매우 강력한 콜라겐 합성촉진 효과가 있음을 밝혀 내고 본 발명을 완성하게 되었다. 본 발명의 유효성분인 8-히드록시버갑텐의 콜라겐합성능 및 피부 주름 개선효과에 관해서는 기존의 어떠한 연구도 없었다. The inventors of the present invention, while developing a substance having an excellent collagen synthesis promoting effect as an active ingredient of the cosmetic composition for improving skin wrinkles, found that the 8-hydroxybuffapten has a very strong collagen synthesis promoting effect and completed the present invention. It became. There has been no previous study on the collagen synthesis performance and skin wrinkle improvement effect of 8-hydroxybuffapten, the active ingredient of the present invention.

상기 8-히드록시버갑텐은 하기 화학식 1로 표현된다.The 8-hydroxy buffapten is represented by the following formula (1).

Figure 112003038735654-pat00001
Figure 112003038735654-pat00001

천연상태의 8-히드록시버갑텐은 주로 산형목과 식물의 뿌리에 존재하는 화합물이다. 8-히드록시버갑텐을 얻을 수 있는 방법으로는 여러 가지가 있을 수 있다. 예를 들면 산형목과 식물인 구릿대의 뿌리(백지)를 잘게 잘라서 물, 탄소수 1 내지 4의 무수 또는 함수 저급 알코올, 에틸아세테이트, 아세톤, 클로로포름 또는 이들의 혼합물을 첨가하여 가온 추출하고, 용매분획한 후 재결정화함으로써 얻을 수 있다. Natural 8-hydroxybuffapten is a compound mainly found in hawthorn and plant roots. There can be several ways to obtain 8-hydroxybuffaptene. For example, finely chopped roots (white paper) of hawthorns and plants, added with water, anhydrous or hydrous lower alcohols having 1 to 4 carbon atoms, ethyl acetate, acetone, chloroform or a mixture thereof, and extracted by heating, and solvent fractionation. Obtained by recrystallization.

8-히드록시버갑텐을 유효성분으로 포함하는 피부 주름 개선용 화장료 조성물을 제조하여 인체에 적용함으로써, 우수한 피부의 탄력과 피부주름개선 효과를 얻을 수 있다. 이 때 피부주름 개선용 화장료 조성물은 콜라겐 생성촉진제로서 8-히 드록시버갑텐을 전체 중량 대비 0.000001 중량% 내지 10 중량% 포함할 수 있으며, 바람직하게는 0.001중량% 포함할 수 있고, 더욱 바람직하게는 0.1 중량% 내지 10 중량%를 포함할 수 있다. 8-히드록시버갑텐의 함량이 0.000001 중량% 미만인 경우에는 뚜렷한 효과를 기대할 수 없고, 10 중량%를 초과하는 경우에는 포함량의 증가에 비해 효과의 증가가 미치지 못한다. By preparing a cosmetic composition for improving skin wrinkles comprising 8-hydroxy vergatten as an active ingredient and applying it to the human body, it is possible to obtain an excellent skin elasticity and wrinkle improvement effect. In this case, the cosmetic composition for improving skin wrinkles may include 0.000001% by weight to 10% by weight of 8-hydroxybuffapten as a collagen production promoter, preferably 0.001% by weight, and more preferably. May comprise 0.1% to 10% by weight. If the content of 8-hydroxybuffapten is less than 0.000001% by weight, no obvious effect can be expected, and if the content of more than 10% by weight does not increase the effect compared to the increase in the amount of inclusion.

본 발명에 따른 피부주름 개선용 화장료 조성물은 외용연고, 크림, 폼, 화장수, 팩, 유연수, 유액, 파운데이션, 메이크업베이스, 엣센스, 비누, 액체세정료, 입욕제, 선 스크린크림, 또는 선오일 등의 제형으로 제조할 수 있다.The cosmetic composition for improving skin wrinkles according to the present invention is an external ointment, cream, foam, lotion, pack, soft water, emulsion, foundation, makeup base, essence, soap, liquid cleanser, bathing agent, sunscreen cream, or sun oil It may be prepared in a formulation.

또한 본 발명의 화장료 조성물은 일반 피부화장료에 배합되는 통상의 성분, 예를 들면 유분, 물, 계면활성제, 보습제, 저급알콜, 증점제, 킬레이트제, 색소, 방부제, 향료 등을 적절히 배합할 수 있다. In addition, the cosmetic composition of the present invention can be appropriately blended with conventional ingredients, such as oil, water, surfactants, moisturizers, lower alcohols, thickeners, chelating agents, pigments, preservatives, fragrances and the like, which are blended in general skin cosmetics.

이하 본 발명의 이해를 돕기 위하여 바람직한 실시예를 제시하나, 하기 실시예는 본 발명을 예시하는 것일 뿐 본 발명의 범위가 하기 실시예에 한정되는 것은 아니다. Hereinafter, preferred examples are provided to help understanding of the present invention, but the following examples are merely to illustrate the present invention, and the scope of the present invention is not limited to the following examples.

[실시예 1] 8-히드록시버갑텐의 추출 Example 1 Extraction of 8-hydroxybuffapten

1-1: 메탄올을이용한 8-히드록시버갑텐의 추출 1-1: Extraction of 8-hydroxybuffapten with Methanol

백지(Angelica dahurica 또는 Angelica dahurica var. formosana)의 건조된 뿌리 1 kg을 메탄올 10리터에 넣고, 환류냉각기가 달린 추출기에서 80℃로 3시간 가온 추출하여 85 g의 메탄올 추출액을 얻었다. 상기 메탄올 추출액으로부터 용매분획을 통하여 헥산 분획을 제거하고 얻어진 분획을 클로로포름으로 3회 분획 하여 9 g의 클로로포름 분획을 얻었다. 상기 얻어진 클로로포름 분획을 수회에 걸쳐 실리카 컬럼 크로마토그라피(Silica column chromatography)를 통하여 8-히드록시버갑텐을 포함하는 분획 0.2 g을 얻었고, 이 분획을 분취용 HPLC(Prep-HPLC) 및 재결정 방법을 이용하여 8-히드록시버갑텐을 얻었다. 상기 방법으로 얻은 8-히드록시버갑텐은 핵자기공명(NMR)과 질량분석(Mass spectroscopy)을 통하여 성분과 함량(99.7 중량%)을 확인하였다. 도 1과 2는 각각 상기 8-히드록시버갑텐의 1H-NMR 스펙트럼과 13C NMR 스펙트럼을 나타내며, 각 피크(peak)에 기재된 숫자는 도 1 및 2의 화학식에 기재된 숫자에 대응된다. 또한, 도 3은 상기 8-히드록시버갑텐의 Mass 스펙트럼을 나타낸다. 1 kg of dried root of white paper (Angelica dahurica or Angelica dahurica var. Formosana) was placed in 10 liters of methanol, and extracted by heating at 80 ° C. for 3 hours in an extractor equipped with a reflux condenser to obtain 85 g of methanol extract. The hexane fraction was removed from the methanol extract through solvent fractionation, and the obtained fraction was fractionated three times with chloroform to obtain 9 g of chloroform fraction. The obtained chloroform fraction was subjected to silica column chromatography several times to obtain 0.2 g of a fraction containing 8-hydroxybuffatten, which was purified by preparative HPLC (Prep-HPLC) and recrystallization. To obtain 8-hydroxybuffaptene. The 8-hydroxybuffapten obtained by the above method was identified by its nuclear magnetic resonance (NMR) and mass spectroscopy (99.7% by weight). 1 and 2 show 1 H-NMR spectra and 13 C NMR spectra of the 8-hydroxybuffapten, respectively, and the numbers described in each peak correspond to the numbers described in the chemical formulas of FIGS. 3 shows the mass spectrum of the 8-hydroxybuffapten.

1-2: 클로로포름을 이용한 8-히드록시버갑텐 추출 1-2: 8-hydroxybuffapten extraction using chloroform

백지의 건조된 뿌리 1 kg을 클로로포름 10리터에 넣고 환류냉각기가 달린 추출기에서 100℃ 3시간 가온 추출하여 클로로포름 추출액 12 g을 얻었다. 상기 클로로포름 추출액을 클로로포름에 녹이고 알카리수용액(0.1M NaOH 수용액)으로 용매분획하여 알카리수용액 가용부를 얻은 후, HCl로 중화시키고 클로로포름으로 용매분획하여 얻은 클로로포름 분획 1 g을 분취용 HPLC(Prep-HPLC) 및 재결정 방법을 이용하여 8-히드록시버갑텐을 얻었다. 상기 방법으로 얻은 8-히드록시버갑텐은 핵자기공명(NMR)과 질량분석(Mass spectroscopy)을 통하여 성분과 함량(99.7중량%)을 확인하였다. 1 kg of dried root of white paper was added to 10 liters of chloroform, and extracted by heating at 100 ° C. for 3 hours in an extractor equipped with a reflux condenser to obtain 12 g of chloroform extract. The chloroform extract was dissolved in chloroform, and the solvent was fractionated with an alkaline aqueous solution (0.1 M NaOH aqueous solution) to obtain an alkaline aqueous solution soluble part. 8-hydroxybuffaptene was obtained using the recrystallization method. The 8-hydroxybuffapten obtained by the above method was identified by the component and content (99.7% by weight) through nuclear magnetic resonance (NMR) and mass spectroscopy (Mass spectroscopy).

[실시예 2] 8-히드록시버갑텐의 콜라겐 생합성 효과 Example 2 Collagen Biosynthesis Effect of 8-hydroxybuffapten                     

8-히드록시버갑텐을 인간유래의 섬유아세포의 배양액에 첨가하여 세포수준에서 피부 주름 개선용 화장료 효과를 실험하였다. 생합성된 콜라겐의 측정은 PICP EIA kit(Procollagen Type I C-Peptide Enzyme ImmunoAssay KIT)를 이용하여 정량하였다. Eight-hydroxybuffapten was added to the culture solution of human-derived fibroblasts, and the cosmetic effect for skin wrinkle improvement at the cellular level was tested. Biosynthetic collagen was measured using a PICP EIA kit (Procollagen Type I C-Peptide Enzyme ImmunoAssay KIT).

8-히드록시버갑텐을 최종농도 0.5 ㎍/ml, 1 ㎍/ml, 2 ㎍/ml, 5 ㎍/ml, 10 ㎍/ml가 되도록 하여 비타민 C(Vitamin C)와 대조군과 함께 각각 인간 유래의 섬유아세포(human fibroblast 세포)의 배양배지에 첨가하여 1일간 배양한 후, 배양액을 취하여 PICP EIA Kit로 각 농도에서 콜라겐 생합성 정도를 분광광도계를 이용하여 450 nm에서 측정하였다. 콜라겐 생성량은 UV흡광도로서 측정하고, 콜라겐 생합성 증가율은 대조군(무첨가)에 대한 상대적인 합성능의 %값으로 계산하여 결과를 표 1에 정리하였다.The final concentration of 8-hydroxybenzogatten is 0.5 μg / ml, 1 μg / ml, 2 μg / ml, 5 μg / ml, 10 μg / ml, together with vitamin C and the control, respectively. After culturing for one day by adding to fibroblasts (human fibroblast cells) culture medium, the culture medium was taken, and the degree of collagen biosynthesis at each concentration was measured at 450 nm using a spectrophotometer with PICP EIA Kit. Collagen production amount was measured as UV absorbance, and collagen biosynthesis increase rate was calculated as a percentage value of the synthetic ability relative to the control (no addition), and the results are summarized in Table 1.

[표 1] 농도에 따른 세포수준에서의 콜라겐 생합성 효과 [Table 1] Collagen Biosynthesis Effect at Cell Level According to Concentration

첨가시료Sample added 적용 농도(㎍/ml)Application concentration (µg / ml) 콜라겐 생성량 (Abs)Collagen production amount (Abs) 증가율(%)% Increase 대조군Control -- 1.310±0.0721.310 ± 0.072 -- 8-히드록시버갑텐8-hydroxybuffapten 0.50.5 1.590±0.1021.590 ± 0.102 121.4121.4 1.01.0 1.876±0.0971.876 ± 0.097 143.2143.2 2.02.0 1.949±0.1111.949 ± 0.111 148.8148.8 5.05.0 1.953±0.1321.953 ± 0.132 149.1149.1 10.010.0 2.008±0.1292.008 ± 0.129 153.3153.3 비타민 CVitamin c 52.852.8 1.757±0.1211.757 ± 0.121 134.1134.1

*반복수 = 6                                                               * Repeat count = 6

표 1의 결과에서 볼 수 있듯이 8-히드록시버갑텐은 인간유래의 섬유아세포에 대하여 우수한 콜라겐 생합성능이 있으며, 일반적으로 콜라겐 합성 능력이 있는 것으로 알려진 비타빈C를 적용한 경우보다 적은 농도로 더 우수한 콜라겐 합성 효과 를 얻을 수 있음을 알 수 있다. As can be seen from the results in Table 1, 8-hydroxybugatten has superior collagen biosynthesis to human-derived fibroblasts, and generally better collagen at a lower concentration than the application of vitabin C, which is generally known to have collagen synthesis ability. It can be seen that a synthetic effect can be obtained.

[실시예 3] 8-히드록시버갑텐의 피부 주름개선 효과 Example 3 Skin Wrinkle Improvement Effect of 8-hydroxybupatten

6주령의 헤어리스 마우스를 이용하여 광에 의해 유발된 피부 주름에 대하여 8-히드록시버갑텐의 피부 주름개선 효과를 시험하였다. 시료는 8-히드록시버갑텐을 1,3-부틸렌글리콜에 5 mg/ml로 녹여 적용하였다. A 6-week-old hairless mouse was used to test the skin wrinkle improvement effect of 8-hydroxybuffapten on skin wrinkles induced by light. The sample was applied by dissolving 8-hydroxybuffapten in 1,3-butylene glycol at 5 mg / ml.

헤어리스 마우스에 태양광 조사기(solar simulator)를 이용하여 2 MED로 1주일에 3일 10주간 조사하여 피부 주름을 형성시키고, 시료를 첨가하지 않은 1,3-부틸렌글리콜을 처리한 대조군과 5 mg/ml의 8-히드록시버갑텐 용액을 1일 2회 0.5 ml/cm2(8-히드록시버갑텐으로 2.5 mg/cm2)씩 6주간 처리한 군을 대상으로 개선 정도를 정성 판단하였다. Hairless mice were irradiated with 2 MED for 3 days and 10 weeks a day using a solar simulator to form skin wrinkles, and the control treated with 1,3-butylene glycol without addition of the sample and 5 The degree of improvement was qualitatively determined in the group treated with 0.5 ml / cm 2 (2.5 mg / cm 2 with 8-hydroxy benzogatten) twice a day for 6 weeks of 8 mg of 8 mg of hydroxybutapten solution. .

주름개선 정도의 판단은 먼저 시료 처리 부위를 육안과 사진 촬영을 통해 육안판정하였고, 판정기준은 시료 처리군 및 대조군을 시료처리전과 비교하여 개선없음, 약간의 개선, 상당한 개선의 3단계로 판정하여 표 2에 나타내었다. Wrinkle improvement was judged by visual inspection and photographing of the sample processing area, and the criterion was judged by three stages of no improvement, slight improvement, and significant improvement compared to the sample treatment group and the control group. Table 2 shows.

[표 2] 마우스에 대한 피부 주름개선효과 [Table 2] Skin wrinkle improvement effect on the mouse

시료sample 개선없음No improvement 약간의 개선Minor improvements 상당한 개선A significant improvement 대조군Control 1010 00 00 8-히드록시버갑텐8-hydroxybuffapten 00 44 66

각 군의 개체수 = 10                                                     Population in each group = 10

[실시예 4 및 비교예 1] 피부 주름 개선용 화장료 엣센스 [Example 4 and Comparative Example 1] cosmetic essence for skin wrinkle improvement

피부 주름 개선용 화장료 엣센스의 제조 Preparation of cosmetic essence for skin wrinkle improvement

8-히드록시버갑텐을 포함하는 피부 주름 개선용 화장료 엣센스의 제형을 실 시예 4로 제조하였으며, 상기 실시예중 8-히드록시버갑텐을 포함하지 않는 것을 제외하고는 실시예 4와 동일하게 화장료 엣센스를 제조한 것을 비교예 1로 하였다. 상세한 조성은 하기 표 3에 나타내었다. Formulation of the skin wrinkle improvement cosmetic essence comprising 8-hydroxy buffapten was prepared in Example 4, except that the formulation does not include 8-hydroxy buffapten cosmetic essence as in Example 4 Was prepared as Comparative Example 1. Detailed compositions are shown in Table 3 below.

[표 3] TABLE 3

조 성 물 Composition water 실시예 4 (중량%)Example 4 (% by weight) 비교예 1 (중량%)Comparative Example 1 (% by weight) 8-히드록시버갑텐8-hydroxybuffapten 1One -- 프로필렌글리콜Propylene glycol 10.010.0 10.010.0 글리세린glycerin 10.010.0 10.010.0 히아루론산나트륨수용액(1%)Sodium hyaluronate aqueous solution (1%) 5.05.0 5.05.0 에탄올ethanol 5.05.0 5.05.0 폴리옥시에틸렌경화피마자유Polyoxyethylene Cured Castor Oil 1.01.0 1.01.0 파라옥시안식향산메틸Methyl paraoxybenzoate 0.10.1 0.10.1 incense 0.050.05 0.050.05 정제수Purified water to 100to 100 to 100to 100

패널 테스트를 통한 피부 주름 개선 효과 실험 Experimental effect of skin wrinkle improvement through panel test

상기 실시예 4과 비교예 1의 엣센스에 대해서 건강한 35세에서 50세의 여성을 대상으로 피부 주름개선 효과를 다음과 같이 시험하였다. The skin wrinkle improvement effect of the essence of Example 4 and Comparative Example 1 was tested in healthy 35 to 50 year old women as follows.

35세에서 50세까지의 여성 30명을 15명씩 2개의 군으로 구분하고 1군은 8-히드록시버갑텐을 1% 포함하는 실시예 4의 엣센스를, 2군은 비교예 1의 엣센스를 안면부에 1일 1회 3개월간 도포하였다. Thirty females from 35 to 50 years old were divided into two groups of 15 people each, and the first group had an essence of Example 4 containing 1% of 8-hydroxybutapten, and the second group had an essence of Comparative Example 1 Was applied once a day for 3 months.

3개월 후 피부 주름의 개선정도를 피험자의 설문 및 피부 주름의 영상분석을 통해 평가하였다. 피험자의 설문은 피부 주름개선 및 탄력증진에 관하여 사용전과 비교하여 개선없음, 약간의 개선, 상당한 개선의 3단계로 판정하였으며 결과는 표 4에 나타내었다. After 3 months, the improvement of skin wrinkles was evaluated by subject's questionnaire and image analysis of skin wrinkles. The subject's questionnaire was judged in three stages of improvement of skin wrinkles and elasticity compared with before use, no improvement, slight improvement, and significant improvement. The results are shown in Table 4.

[표 4] 본 발명에 의한 실시예의 피부 주름개선 효과(명) Table 4 Skin Wrinkle Improvement Effect of the Example of the Present Invention

시 료sample 개선 없음No improvement 약간의 개선Minor improvements 상당한 개선A significant improvement 비교예 1Comparative Example 1 99 55 1One 실시예 4Example 4 -- 77 88

표 4에서 볼 수 있듯이 본 발명에 의한 실시예 4의 엣센스를 사용한 경우 피부 주름 개선 효과가 우수함을 알 수 있다. As can be seen in Table 4, it can be seen that the skin wrinkle improvement effect is excellent when the essence of Example 4 according to the present invention is used.

영상분석을 통한 주름 개선 효과 실험 Wrinkle improvement effect experiment through image analysis

주름의 영상분석에 의한 평가는 실험이 시작되기 전 눈 밑의 레플리카(replica)를 채취하고(Xantopren, Bayer), 실험이 종료된 직후 레플리카를 눈밑의 동일 부위에서 채취하여 영상분석을 통해 피부 주름의 2차원적 분석으로 피부 주름의 밀도를 측정하였다. 영상분석에 의한 피부 주름 밀도의 측정 결과는 표 5에 사용 전 피부 주름밀도 대비 사용후 피부 주름 밀도의 감소율을 평균하여 나타내었다. Image analysis of wrinkles was performed by collecting replicas under the eyes (Xantopren, Bayer) before the experiment was started, and immediately after the experiment was completed, replicas were taken from the same area under the eyes. The density of skin wrinkles was measured by two-dimensional analysis. The measurement results of skin wrinkle density by image analysis are shown in Table 5 by averaging the decrease rate of skin wrinkle density after use compared to skin wrinkle density before use.

[표 5] 피부 주름 개선 효과(영상분석) [Table 5] Skin wrinkle improvement effect (image analysis)

시 료sample 피부 주름밀도 감소율(%)Skin Wrinkle Density Reduction (%) 비 교 예 1Comparative Example 1 99 실 시 예 4Example 4 4747

표 5에서 알 수 있듯이 본 발명에 의한 8-히드록시버갑텐을 첨가한 실시예 4의 엣센스를 도포한 경우 피부 주름의 밀도가 비교예 1의 화장료 조성물에 비해 크게 감소하는 것을 알 수 있다. As can be seen from Table 5, when applying the essence of Example 4 to which the 8-hydroxy vergatenten according to the present invention is applied, it can be seen that the density of the skin wrinkles is significantly reduced compared to the cosmetic composition of Comparative Example 1.

이상 살펴본 실시예 3 및 4에 있어서 본 발명의 8-히드록시버갑텐에 의한 피부자극이나 부작용은 발견되지 않았다.In Examples 3 and 4 described above, no skin irritation or side effects due to the 8-hydroxybutapten of the present invention was found.

이하 8-히드록시버갑텐을 포함하는 피부 주름 개선용 화장료 조성물의 제조 실시예 및 비교예를 나타낸다. Hereinafter, the preparation examples and comparative examples of the cosmetic composition for improving skin wrinkles comprising 8-hydroxybugattenene.

[실시예 5 및 비교예 2] 피부 주름 개선용 피부 외용연고 [Example 5 and Comparative Example 2] skin external ointment for improving skin wrinkles                     

8-히드록시버갑텐을 포함하는 피부 주름 개선용 피부 외용연고의 제형을 실시예 5로 제조하였으며, 상기 실시예 중 8-히드록시버갑텐을 포함하지 않는 것을 제외하고는 실시예 5와 동일하게 피부 외용연고를 제조한 것을 비교예 2로 하였다. 상세한 조성은 하기 표 6에 나타내었다. A formulation of the skin external ointment for improving skin wrinkles including 8-hydroxybuffapten was prepared in Example 5, and the same as in Example 5 except for not including 8-hydroxybuffapten. A skin external ointment was prepared as Comparative Example 2. Detailed compositions are shown in Table 6 below.

[표 6] TABLE 6

조 성 물Composition water 실시예 5 (중량%)Example 5 (% by weight) 비교예 2 (중량%)Comparative Example 2 (wt%) 8-히드록시버갑텐8-hydroxybuffapten 22 -- 디에틸 세바케이트Diethyl sebacate 88 88 경납Prepayment 55 55 폴리옥시에틸렌올레일에테르포스페이트Polyoxyethylene Oleyl Ether Phosphate 66 66 벤조산 나트륨Sodium benzoate 0.10.1 0.10.1 와셀린Waselin to 100to 100 to 100to 100

[실시예 6 및 비교예 3] 피부 주름 개선용 화장료 크림 [Example 6 and Comparative Example 3] cosmetic cream for improving skin wrinkles

8-히드록시버갑텐을 포함하는 피부 주름 개선용 화장료 크림의 제형을 실시예 6으로 제조하였으며, 상기 실시예 중 8-히드록시버갑텐을 포함하지 않는 것을 제외하고는 실시예 6과 동일하게 화장료 크림을 제조한 것을 비교예 3으로 하였다. 상세한 조성은 하기 표 7에 나타내었다. The formulation of the cosmetic cream for skin wrinkle improvement comprising 8-hydroxy benzogaptenen was prepared in Example 6, except that it does not include 8-hydroxy benzogapten, the same as in Example 6 cosmetics A cream was prepared as Comparative Example 3. The detailed composition is shown in Table 7 below.

[표 7] TABLE 7

조 성 물Composition water 실시예 6 (중량%)Example 6 (% by weight) 비교예 3 (중량%)Comparative Example 3 (wt%) 8-히드록시버갑텐8-hydroxybuffapten 0.50.5 -- 스테아린산Stearic acid 15.015.0 15.015.0 세탄올Cetanol 1.01.0 1.01.0 수산화칼륨Potassium hydroxide 0.70.7 0.70.7 글리세린glycerin 5.05.0 5.05.0 프로필렌글리콜Propylene glycol 3.03.0 3.03.0 방부제antiseptic 0.050.05 0.050.05 incense 0.050.05 0.050.05 정제수Purified water to 100to 100 to 100to 100

[실시예 7 및 비교예 4] 피부 주름 개선용 유연화장수 [Example 7 and Comparative Example 4] supple cosmetics for improving skin wrinkles

8-히드록시버갑텐을 포함하는 피부 주름 개선용 유연화장수의 제형을 실시예 7로 제조하였으며, 상기 실시예 중 8-히드록시버갑텐을 포함하지 않는 것을 제외하고는 실시예 7과 동일하게 유연화장수를 제조한 것을 비교예 4으로 하였다. 상세한 조성은 하기 표 8에 나타내었다. Formulation of the softening longevity for improving skin wrinkles including 8-hydroxy benzogapten was prepared in Example 7, and the same as in Example 7 except that it does not include 8-hydroxy bogapten What manufactured long life was made into the comparative example 4. The detailed composition is shown in Table 8 below.

[표 8] TABLE 8

조 성 물Composition water 실시예 7 (중량%)Example 7 (% by weight) 비교예 4 (중량%)Comparative Example 4 (wt%) 8-히드록시버갑텐8-hydroxybuffapten 0.20.2 -- 에탄올ethanol 10.010.0 10.010.0 폴리라우린산폴리옥시에틸렌소르비탄Polylauric acid polyoxyethylene sorbitan 1.01.0 1.01.0 파라옥시안식향산메틸Methyl paraoxybenzoate 0.20.2 0.20.2 글리세린glycerin 5.05.0 5.05.0 1,3-부틸렌글리콜1,3-butylene glycol 6.06.0 6.06.0 incense 0.050.05 0.050.05 색소Pigment 0.050.05 0.050.05 정제수Purified water to 100to 100 to 100to 100

[실시예 8 및 비교예 5] 피부 주름 개선용 영양화장수 [Example 8 and Comparative Example 5] nourishing cosmetics for improving skin wrinkles

8-히드록시버갑텐을 포함하는 피부 주름 개선용 영양화장수의 제형을 실시예 8로 제조하였으며, 상기 실시예 중 8-히드록시버갑텐을 포함하지 않는 것을 제외하고는 실시예 8과 동일하게 영양화장수를 제조한 것을 비교예 5로 하였다. 상세한 조성은 하기 표 9에 나타내었다. Formulation of nourishing longevity for improving skin wrinkles containing 8-hydroxy benzogapten was prepared in Example 8, except that it does not include 8-hydroxy bogaptene in the same manner as in Example 8 What used the lotion was made into the comparative example 5. Detailed compositions are shown in Table 9 below.

[표 9] TABLE 9

조 성 물 Composition water 실시예 8 (중량%)Example 8 (% by weight) 비교예 5 (중량%)Comparative Example 5 (wt%) 8-히드록시버갑텐8-hydroxybuffapten 0.10.1 -- 와셀린Waselin 2.02.0 2.02.0 세스퀴올레인산소르비탄Sesquioleate sorbitan 0.80.8 0.80.8 폴리옥시에틸렌올레일에틸Polyoxyethylene oleylethyl 1.21.2 1.21.2 파라옥시안식향산메틸Methyl paraoxybenzoate 0.10.1 0.10.1 프로필렌글리콜Propylene glycol 5.05.0 5.05.0 에탄올ethanol 3.23.2 3.23.2 카르복시비닐폴리머Carboxy Vinyl Polymer 18.018.0 18.018.0 수산화칼륨Potassium hydroxide 0.10.1 0.10.1 색소Pigment 0.050.05 0.050.05 incense 0.050.05 0.050.05 정제수Purified water to 100to 100 to 100to 100

[실시예 9 및 비교예 6] 피부 주름 개선용 화장료 팩 [Example 9 and Comparative Example 6] cosmetic pack for improving skin wrinkles                     

8-히드록시버갑텐을 포함하는 피부 주름 개선용 화장료 팩의 제형을 실시예 9로 제조하였으며, 상기 실시예 중 8-히드록시버갑텐을 포함하지 않는 것을 제외하고는 실시예 9와 동일하게 화장료 팩을 제조한 것을 비교예 6으로 하였다. 상세한 조성은 하기 표 10에 나타내었다. The formulation of the cosmetic pack for improving skin wrinkles containing 8-hydroxy buffaptene was prepared in Example 9, except that the formulation of the same as in Example 9 except that it does not include 8-hydroxy buffapten What manufactured the pack was made into the comparative example 6. The detailed composition is shown in Table 10 below.

[표 10] TABLE 10

조 성 물 Composition water 실시예 9 (중량%)Example 9 (% by weight) 비교예 6 (중량%)Comparative Example 6 (wt%) 8-히드록시버갑텐8-hydroxybuffapten 0.20.2 -- 글리세린glycerin 5.05.0 5.05.0 프로필렌글리콜Propylene glycol 4.04.0 4.04.0 폴리비닐알코올Polyvinyl alcohol 15.015.0 15.015.0 에탄올ethanol 8.08.0 8.08.0 폴리옥시에틸렌올레일에틸Polyoxyethylene oleylethyl 1.01.0 1.01.0 파라옥시안식향산메틸Methyl paraoxybenzoate 0.20.2 0.20.2 색소Pigment 0.050.05 0.050.05 incense 0.050.05 0.050.05 정제수Purified water to 100to 100 to 100to 100

이상 살펴본 바와 같이 8-히드록시버갑텐을 유효성분으로 포함하는 피부 주름 개선용 화장료 조성물은 피부의 섬유아세포에 대하여 매우 강력한 피부 주름 개선용 화장료 효과를 나타내었으며, 헤어리스 마우스를 이용한 피부 주름 개선 효과 시험에 있어서도 매우 우수한 피부 주름 개선 효과를 나타내었다. As described above, the cosmetic composition for improving skin wrinkles comprising 8-hydroxybuffapten as an active ingredient showed a very powerful cosmetic effect for improving skin wrinkles against fibroblasts of the skin, and a skin wrinkle improving effect using a hairless mouse. The test also showed a very good skin wrinkle improvement.

본 발명의 피부 주름 개선용 화장료 조성물은 콜라겐 합성 촉진제로서 8-히드록시버갑텐(8-hydroxybergapten : 5-benzofuranacrylic acid,6,7-dihydroxy-4-methoxy-,δ-lactone)을 포함하여 피부의 섬유아세포의 콜라겐합성을 촉진함으로써, 피부의 탄력을 향상시키고, 피부 주름을 개선하는 효과가 매우 우수하다. The cosmetic composition for improving skin wrinkles of the present invention comprises 8-hydroxybergapten (5-benzofuranacrylic acid, 6,7-dihydroxy-4-methoxy-, δ-lactone) as a collagen synthesis promoter. By promoting collagen synthesis of fibroblasts, the effect of improving skin elasticity and improving skin wrinkles is very excellent.

Claims (5)

8-히드록시버갑텐(8-hydroxybergapten : 5-benzofuranacrylic acid,6,7-dihydroxy-4-methoxy-,δ-lactone)을 유효성분으로 포함하는 화장료 조성물.Cosmetic composition comprising 8-hydroxybergapten (8-hydroxybergapten: 5-benzofuranacrylic acid, 6,7-dihydroxy-4-methoxy-, δ-lactone) as an active ingredient. 8-히드록시버갑텐을 유효성분으로 포함하는 피부 주름 개선용 화장료 조성물. A cosmetic composition for improving skin wrinkles comprising 8-hydroxybuffapten as an active ingredient. 제 2항에 있어서, 상기 피부 주름 개선용 화장료 조성물은 8-히드록시버갑텐을 전체 조성물 중량에 대하여 0.000001 중량% 내지 10 중량% 포함하는 피부 주름 개선용 화장료 조성물. The cosmetic composition for improving skin wrinkles according to claim 2, wherein the cosmetic composition for improving skin wrinkles comprises 8-hydroxybuffapten from 0.000001 wt% to 10 wt% based on the total weight of the composition. 제 2항에 있어서, 상기 피부 주름 개선용 화장료 조성물은 8-히드록시버갑텐을 전체 조성물 중량에 대하여 0.1 중량% 내지 10 중량% 포함하는 피부 주름 개선용 화장료 조성물. The cosmetic composition for improving skin wrinkles according to claim 2, wherein the cosmetic composition for improving skin wrinkles comprises 0.1 wt% to 10 wt% of 8-hydroxybuffapten based on the total weight of the composition. 제 2항에 있어서, 상기 피부 주름 개선용 화장료 조성물은 외용연고, 크림, 폼, 화장수, 팩, 유연수, 유액, 파운데이션, 메이크업베이스, 엣센스, 비누, 액체세정료, 입욕제, 선 스크린크림, 및 선오일로 이루어진 군으로부터 선택되는 제형 을 갖는 피부 주름 개선용 화장료 조성물. According to claim 2, wherein the cosmetic composition for improving skin wrinkles ointment, cream, foam, lotion, pack, soft water, latex, foundation, makeup base, essence, soap, liquid cleanser, bath, sunscreen cream, and sun Cosmetic composition for improving skin wrinkles having a formulation selected from the group consisting of oils.
KR1020030072540A 2003-10-17 2003-10-17 Cosmetic Composition against Aging of the Skin KR100769578B1 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
KR1020030072540A KR100769578B1 (en) 2003-10-17 2003-10-17 Cosmetic Composition against Aging of the Skin
JP2006535260A JP4129475B2 (en) 2003-10-17 2004-09-21 Collagen synthesis promoter and skin external preparation composition containing the same
US10/575,974 US20070065377A1 (en) 2003-10-17 2004-09-21 Composition for promoting synthesis of collagen, and composition for external preparation for skin comprising the same
PCT/KR2004/002418 WO2005037270A1 (en) 2003-10-17 2004-09-21 Composition for promoting synthesis of collagen, and composition for external preparation for skin comprising the same
CNB2004800336572A CN100542527C (en) 2003-10-17 2004-09-21 Promote synthetic compositions of collagen and the preparation for external application to skin compositions that comprises it
US12/405,964 US20090233997A1 (en) 2003-10-17 2009-03-17 Composition for promoting synthesis of collagen, and composition for external preparation for skin comprising the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020030072540A KR100769578B1 (en) 2003-10-17 2003-10-17 Cosmetic Composition against Aging of the Skin

Publications (2)

Publication Number Publication Date
KR20050037105A KR20050037105A (en) 2005-04-21
KR100769578B1 true KR100769578B1 (en) 2007-10-23

Family

ID=37239988

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020030072540A KR100769578B1 (en) 2003-10-17 2003-10-17 Cosmetic Composition against Aging of the Skin

Country Status (1)

Country Link
KR (1) KR100769578B1 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001131050A (en) * 1999-11-08 2001-05-15 Kanebo Ltd Skin cosmetic
KR100361592B1 (en) * 2000-09-28 2002-11-22 한불화장품주식회사 An extract of angelica dahurica and angelica tenuissima and a cosmetic composition therefrom

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001131050A (en) * 1999-11-08 2001-05-15 Kanebo Ltd Skin cosmetic
KR100361592B1 (en) * 2000-09-28 2002-11-22 한불화장품주식회사 An extract of angelica dahurica and angelica tenuissima and a cosmetic composition therefrom

Also Published As

Publication number Publication date
KR20050037105A (en) 2005-04-21

Similar Documents

Publication Publication Date Title
KR20080111791A (en) Anti-wrinkle cosmetic composition
KR101860109B1 (en) Skin external composition containing floral ginsenoside
KR101418986B1 (en) Composition for promoting collagen synthesis and cosmetics comprising the same
KR20030024932A (en) Cosmetic composition containing centella asiatica extracts
KR20080093500A (en) Cosmetic compositions for preventing skin aging comprising extract astilbe chinensis var. davidii
US20090233997A1 (en) Composition for promoting synthesis of collagen, and composition for external preparation for skin comprising the same
KR101418979B1 (en) Compositions for promotion of collagen synthesis and cosmetics using the same
KR100769577B1 (en) Cosmetic Composition against Aging of the Skin
KR100769579B1 (en) Cosmetic composition against aging of the skin
KR100769578B1 (en) Cosmetic Composition against Aging of the Skin
KR101416993B1 (en) Anti-wrinkle cosmetic composition
KR101145814B1 (en) Composition for improving skin wrinkle
US20230270660A1 (en) Silybum marianum (L.) Gaertn. oil for reinforcing the barrier function of the skin
KR101897570B1 (en) Composition for anti-wrinkle comprising handroanthus impetiginosus extract and method for preparing the extract
KR100467501B1 (en) A cosmetic composite
KR20050037107A (en) Cosmetic composition against aging of the skin
KR20070111025A (en) Anti-wrinkle cosmetic compositions comprising the extract of phaseolus radiatus as active ingredient
KR20140045213A (en) Compositions for improving skin wrinkle or enhancing skin elasticity comprising rebaudioside as an active ingredient
KR20050037106A (en) Composition for wound healing
KR102494687B1 (en) Cosmetic composition containing fermented products of truffle mushroom as active ingredient
KR100834697B1 (en) Cosmetics or pharmaceutical composition containing extract of zanthoxylum bungeanum maxim, hyoscyamus niger l. or luffa cylindrica (l.) roem
KR100542824B1 (en) Skin composition for wrinkle improvement, elasticity improvement and wound healing, including collagen synthesis promoter
KR101526592B1 (en) Anti-wrinkle composition
KR20080069816A (en) Composition for improving wrinkle and elasticity
JP3276701B2 (en) Wrinkle improver and keratosis improver

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20120914

Year of fee payment: 6

FPAY Annual fee payment

Payment date: 20130913

Year of fee payment: 7

FPAY Annual fee payment

Payment date: 20140917

Year of fee payment: 8

FPAY Annual fee payment

Payment date: 20150917

Year of fee payment: 9

FPAY Annual fee payment

Payment date: 20160919

Year of fee payment: 10

FPAY Annual fee payment

Payment date: 20170928

Year of fee payment: 11

FPAY Annual fee payment

Payment date: 20180927

Year of fee payment: 12

FPAY Annual fee payment

Payment date: 20191014

Year of fee payment: 13